As of Mar 16
| -0.09 / -4.35%|
The 5 analysts offering 12-month price forecasts for Synergy Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 13.00 and a low estimate of 2.35. The median estimate represents a +253.54% increase from the last price of 1.98.
The current consensus among 6 polled investment analysts is to Buy stock in Synergy Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.